Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Revenue projections:

Investors may react cautiously to news that DVA's revenues are forecasted to be lower than last year's. Such declines are likely to have a negative effect on the company's bottom line, which can lead to concerns about profitability and hinder investor confidence in the company's future performance.

Financial Ratios:

currentRatio	1.467000
forwardPE	10.907874
debtToEquity	1241.986000
earningsGrowth	0.558000
revenueGrowth	0.052000
grossMargins	0.323640
operatingMargins	0.160610
trailingEps	11.840000
forwardEps	17.143580

DVA's current ratio of 1.467 reflects its strong liquidity position. The company has enough cash reserves and current assets to service its short-term debt obligations, signaling that DVA is financially well-prepared to meet its liabilities without difficulty.
With DaVita Inc.'s Forward PE in a favorable range, the stock appears reasonably priced compared to its earnings. This suggests that it's not overpriced and there is room for growth, providing an encouraging opportunity for investors seeking future value increases.
DaVita Inc.'s high debt-to-equity ratio indicates the company is using significant leverage, relying more on debt to finance its operations. This can lead to higher risk, especially if profitability falters or economic conditions worsen.
DaVita Inc.'s forward EPS surpasses its trailing EPS, reflecting expectations of higher profitability in the current year. This suggests that DaVita Inc. is projected to generate stronger earnings, indicating an optimistic financial outlook compared to the prior year's results.

Price projections:

The stock price of DVA has often been near the lower end of projections, indicating that it may not be meeting investor expectations. This trend could suggest challenges ahead for the company.

Insider Transactions:

10 sales of DVA stock were made, with market price at 183.76799850463868 per share.During the period under consideration, there were no sell transactions.More buys than sells have been occurring around the current price levels of DVA, potentially signaling investor optimism. This buying trend might be interpreted as a sign of a favorable outlook for the stock's future performance.

Recommendation changes over time:

Analysts have shown a buy bias for DVA, marking it as a favorable investment option. This could inspire investors to see DVA as a strong place to park their money, given the positive outlook and growth potential associated with the stock in recent evaluations.